In other countries
The same active substances on other registers, the same brand first.
- AdtralzaCanada · 150 MG / ML · Solution · Leo Pharma INCSame brand
- AdtralzaCanada · 300 MG / 2 ML · Solution · Leo Pharma INCSame brand
- ADTRALZA 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADASpain · 150 mg · solución inyectable · Leo Pharma A/SSame brand
- Adtralza 300 MG Solucion Inyectable en Pluma PrecargadaSpain · 300 mg · solución inyectable · Leo Pharma A/SSame brand
- AdtralzaEuropean Union · LEO Pharma A/SSame brand
- AdtralzaItaly · Soluzione iniettabile · Leo Pharma A/SSame brand
- Adtralza 150 mg/ml, oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · LEO Pharma A/SSame brand
- Adtralza 300 mg, oplossing voor injectie in voorgevulde penNetherlands · Oplossing voor injectie · LEO Pharma A/SSame brand
- AdtralzaSaudi Arabia · Catalent Indiana LLC formerly Cook Pharmica LLCSame brand
- AdbryUnited States · 300MG/2ML · Injection · LEO Pharma A/SSame substance
- AdbryUnited States · 150MG/ML · injectable · Leo Pharma AsSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED — Agencija za lijekove i medicinske proizvode RH
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Tralokinumab
- Register
- Croatia (HALMED)
- Status
- Authorised
- Registration
- 16242
- ATC code
- D11AH07
- Group
- Dermatologicals
- Procedure
- EU centralised
- Supply
- na recept; u ljekarni